Confocal laser microscopy of dystrophin localization in guinea pig skeletal muscle fibers by unknown
Confocal Laser Microscopy of Dystrophin Localization 
in Guinea Pig Skeletal Muscle Fibers 
Toshikazu Masuda, Noboru Fujimaki, Eijiro Ozawa,* and Harunori Ishikawa 
Department of Anatomy, Gunma University School of Medicine, Maebashi, Gunma 371, Japan; and *  Division of Cell Biology, 
National Institute of Neuroscience, NCNE Kodaira, Tokyo, 187, Japan 
Abstract.  A  confocal laser microscope was used to 
analyze the localization pattern of dystrophin along the 
sarcolemma in guinea pig skeletal muscle fibers.  Hind 
leg muscles of the normal animals  were freshly dis- 
sected and frozen for cryostat sections, which were 
then stained with a monoclonal antidystrophin  anti- 
body. In confocal laser microscopy, immunofluores- 
cence staining in relatively thick sections could be 
sharply imaged in thin  optical sections.  When longitu- 
dinal and transverse sections of muscle fibers were ex- 
amined,  the immunostaining  of dystrophin was seen as 
linearly aligned fluorescent dots or intermittent lines 
along the sarcolemma.  In longitudinally cut muscle 
fibers, many fluorescent dots, but not all, corresponded 
to the sarcomere pattern,  especially the I band.  Sec- 
tions cut tangential  to the sarcolemma also showed a 
lattice-like pattern of longitudinal  and transverse stria- 
tions of fluorescent dots.  Double staining for dystro- 
phin and vinculin showed that the two proteins were 
not exactly colocalized.  The end portions of muscle 
fibers were much more intensely stained with antidys- 
trophin antibody than the central portions,  following 
the contour of elaborate surface specializations at the 
myo-tendon junction. The staining pattern at the myo- 
tendon junction was also discontinuous. These confocal 
microscopic observations suggest that dystrophin may 
be localized in a nonuniform, discontinuous pattern 
along the sarcolemma and in some relationship with the 
underlying myofibrils. 
ucrisNr~s  muscular dystrophy  (DMD) is  an Xp21- 
linked recessive disease of muscle necrosis and wast- 
ing. This disease has recently been demonstrated to 
be caused by deficiency of a single gene product named dys- 
trophin (Hoffman et al., 1987). Indeed, dystrophin is not de- 
tected in muscles of DMD patients (Sugita et al., 1988; Zu- 
brzycka-Gaarn et al.,  1988; Hoffman et al.,  1988) and the 
mdx mice (Hoffman et al., 1987; Sugita et al., 1988). Since 
the cDNA sequence of dystrophin has been completely deter- 
mined (Koenig et al., 1987), antibodies can be raised against 
various  segments  of the dystrophin  molecule using its syn- 
thetic  peptides (Hoffman  et al.,  1987; Sugita  et al.,  1988; 
Zubrzycka-Gaarn et ai., 1988). It has been well documented 
from immunofluorescence studies that dystrophin is localized 
at the sarcolemma in normal skeletal  muscle fibers (Sugita 
et al., 1988; Zubrzycka-Gaarn et al.,  1988; Arahata et al., 
1988).  Immunoelectron  microscopic studies  have demon- 
strated the dystrophin localization on the cytoplasmic face of 
the sarcolemma (Watkins et al.,  1988; Cullen  et al.,  1990; 
Wakayama and Shibuya,  1990, 1991), probably constituting 
the membrane cytoskeleton (Mandel, 1989). In conventional 
immunofluorescence microscopy, dystrophin is usually stained 
continuously along the sarcolemma, as described by many in- 
vestigators.  However some preparations  with a monoclonal 
antidystrophin  antibody showed a nonuniform  and even dis- 
continuous pattern of fluorescence staining along the sarco- 
lemma. Hence, we used a confocal laser microscope to deter- 
mine more precise pattern of the dystrophin  staining. 
Materials and Methods 
Antibodies 
The mAb (4-4C5) used was kindly provided by Ajinomoto Co. and Fujire- 
bio Inc. (Tokyo, Japan). It was raised in a mouse against a synthetic polypep- 
tide corresponding to the COOH-terminal region (amino acid residues from 
3495  to  3544)  of the human dystrophin sequence.  FITC-labeled  goat 
anti-mouse IgG (H+L) was purchased from Cappel Laboratories (Mal- 
vern, PA). Texas red-labeled goat anti-mouse IgG+IgM (E-Y Laborato- 
ties, Inc.,  San Mateo,  CA) and FITC-labeled  phalloidin (Sigma Chem- 
ical Co.,  St.  Louis,  MO) were used for double staining for dystrophin 
and F-actin.  Polyclonal  rabbit anti-vinculin antibody (Transformation  Re- 
search,  Inc., Framingham, MA) and FITC-labeled  goat anti-rabbit IgG 
(H+L) (Wako Chemical Industries,  Osaka,  Japan) were used for double 
staining with antidystrophin. 
Immunofluorescence Staining 
Male guinea pigs of '~200 g body weight were used for this study. They 
were anesthetized with ether, and their hind leg muscles were dissected out. 
After cut  into small blocks,  they  were  pasted on disks  of cork using 
tragacanth gum (Wako Chemical Industries).  They were  then frozen  in 
isopentane cooled by liquid nitrogen within 3 rain after dissection,  Serial 
8-10-ttm sections from the guinea pig muscle blocks were cut in a cryostat 
and placed on gelatin-coated  slide glasses.  After being air dried at room 
temperature for 30 rain, they were fixed with cold acetone for 10 rain and 
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pH 7.2, at room temperature for 1 h. Then they were allowed to react with 
a monoclonal antidystrophin antibody (4-4C5,  IgG) in PBS containing 1% 
BSA for 1 h. They were washed 3 times with PBS for 10 min each, incubated 
with FITC-labeled goat anti-mouse IgG (H +L) as a second antibody in PBS 
containing 1% BSA for 1 h, and then washed again in the same way. For 
double staining of dystrophin and F-actin,  specimens were first immunola- 
beled with monoclonal antidystrophin  antibody, treated with Texas red-con- 
jugated goat anti-mouse IgG+IgM as a second antibody, followed by FITC- 
labeled phalloidin staining. For double staining of dystrophin and vinculin, 
specimens  were immunolabeled with a mixture of monoclonal  antidystro- 
phin and polyclonal antivinculin  antibodies, washed, treated with a mixture 
of Texas red-conjugated goat anti-mouse IgG+IgM and FITC-conjugated 
anti-rabbit IgG (H+L). The sections were mounted with 90% glycerol in 
PBS containing 5 % 1,4-diazabicyclol octane (DABCO) (Aldrich Chemical 
Co.,  Milwaukee,  WI) as an antiquenching agent. 
Epifluorescence and Confocal Laser Microscopy 
For conventional  epifluorescence  microscopy,  sections were viewed using 
a Zeiss Axiophot (Carl Zeiss,  Inc., Thornwood, NY) with an epifluores- 
cence attachment  and Plan-Apochromat oil immersion objective lens (100 x 
1.3 NA or 63x  1.4 NA). For confocal laser microscopy,  a Bio-Rad Laser- 
sharp MRC-600 (Bio-Rad Laboratories, Richmond, CA) fitted on a Zeiss 
Axiophot with the same lens was used. 
lmmunoblot Analysis 
Cryostat  sections were suspended in I0 vols of SDS solution containing 30 
mM Tris-HC1, pH 6.8, 10% SDS, 2.5%/3-mercaptoethanol, 5% glycerol, 
and then boiled for 3 min.  SDS-PAGE was performed by the method of 
Laemrnli  in 6% acrylamide slab gels (Laemmli,  1975). For imrnunoblot- 
ting, the electrophoresed  polypeptides  were transferred  onto Immobilon-p 
membrane (Millipore Corp.,  Bedford,  MA) according to the method of 
Kyhse-Anderson  (1984). Proteins on the membrane were allowed to react 
with the monoclonal antidystrophin antibody (4-4C5).  The antibody was 
detected  with an ABC kit (Vectastain;  Vecter Laboratories, Inc., Burlin- 
game,  CA) and then with Immunostain HRP IS-50B  (Konica,  Tokyo, Ja- 
pan).  Molecular weight markers were 450 kD laminin A (Cooper et al., 
1981), 205 kD myosin,  116 kD/3-galactosidase,  and 97.4 kD phosphorylase 
b (Sigma Chemical Co.). 
Figure  1.  Immunoblot  analysis  of 
antidystrophin antibody 4-4C5. Nor- 
mal guinea pig hind leg muscle ex- 
tract was electrophoresed.  (Lane 1 ) 
Coomassie brilliant blue stain. Num- 
bers  on  the  left indicate  molecular 
masses  of  marker  proteins  in  kD. 
(Lane  2)  Immunoblot  using  rnAb 
4-4C5. Only a single protein band of 
~400 kD  is stained. 
Results 
As shown by immunoblot analysis, antidystrophin antibody 
(4-4C5)  used for this study stained a single band of guinea 
pig skeletal muscle extracts without nonspecific reaction. Its 
molecular mass was  '~400 kD as judged from its electro- 
phoretic mobility (Fig.  I). 
In  conventional epifluorescence microscopy,  transverse 
sections of normal skeletal muscle fibers showed a selective 
immunostaining of dystrophin along the sarcolemma (Fig. 2 
A). The staining was usually seen as continuous lines along 
each muscle fiber.  However,  when we looked carefully at 
those fluorescent lines,  they were  not uniformly stained, 
showing intermittent or periodic  staining patterns.  There 
was no significant immunostaining inside the muscle fiber. 
The control sections incubated in PBS containing 1% BSA 
without antidystrophin antibody did not show any staining 
along the sarcolemma (data not shown). 
For further analysis of such a nonuniform appearance of 
immunostaining, we took advantage of using a confocal laser 
microscope (Fig. 2 B). In confocal laser microscopy, sharp 
optical section images were obtained from relatively thick 
sections. In transverse sections two apposed sarcolemmas of 
adjacent muscle fibers could be almost always recognized. 
The staining was discontinuous, showing linearly aligned 
dots or intermittent lines along the sarcolemma. In some 
parts the interval of such dots was quite regular. Such discon- 
Figure 2.  Comparison between a conventional epifluorescence (A) 
and a confocai laser microscope image (B) of the same transverse 
section stained with antidystrophin. The nonuniform staining pat- 
tern  is  more  prominently  recognized  in the  confocal  image,  in 
which the sarcolemmal staining appears as linearly aligned dots or 
intermittent lines (arrows).  In some parts,  the dots  are regularly 
spaced.  Bar,  10 ~m. 
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within the whole thickness of a  section (data not shown). 
In longitudinal sections, dystrophin immunostaining also 
appeared as intermittent lines along the sarcolemma (Fig. 3). 
The center-to-center distance between fluorescent dots was 
1-3 #m. Regular cross striations were faintly observed inside 
the fibers, though the significance of such intracellular stain- 
ing was not clarified. Interestingly, many fluorescent dots, 
but not all, corresponded to the sarcomere pattern. Double 
staining  with  antidystrophin  antibody  and  phalloidin  re- 
vealed that dystrophin staining along the sarcolemma was 
situated preferentially at the level of the I band of underlying 
myofibrils (Fig. 4, A-C).  Phalloidin was used to stain the I 
bands,  since it is a cyclic peptide that specifically binds to 
F-actin (Wulf et al.,  1979). 
The intermittent or periodic pattern of dystrophin staining 
was also seen in sections cut tangential to the sarcolemma, 
showing  a  lattice-like pattern on the  sarcolemma (Fig.  5, 
A-C).  Such staining pattern consisted of transverse and lon- 
gitudinal striations, along which fluorescent dots were more 
or less regularly aligned. The transverse striations often ap- 
peared to correspond to the sarcomere pattern,  while the 
longitudinal striations ran parallel to each other with nonuni- 
form distances.  When muscle fibers were immunostained 
with antivinculin, vinculin was also seen to be distributed in 
transverse striations along the sarcolemma. The striations of 
vinculin were regularly spaced,  well corresponding to the 
sarcomere pattern.  Double  staining  with antivinculin and 
antidystrophin antibodies clearly showed that both proteins 
were not exactly colocalized along the sarcolemma, though 
their fluorescence was partly superimposed (Fig.  6, A and 
B). Interestingly, dystrophin was less regularly spaced and 
more densely distributed than vinculin. 
At  the  end  portions  of muscle  fibers,  dystrophin  was 
stained  much  more intensely than  at  the central portions 
(Fig. 7 A). The staining was seen as thick lines along the sar- 
colemma following the contour of elaborate processes and 
invaginations characteristic of the myo-tendon junction. In 
confocal laser microscopy, the staining of dystrophin was 
also nonuniform, intermittent along the sarcolemma, though 
the fluorescence was much broader and more continuous in 
the end portion than in the central one (Fig. 7 B). Cellular 
profiles in the tendon were weakly fluorescent in the same 
preparations. However, the control sections without the first 
antibody also showed weak staining of cellular profiles in the 
tendon  (data  not  shown),  suggesting  that  this  staining  is 
nonspecific. 
Discussion 
The present study has demonstrated the discontinuous, inter- 
mittent pattern of immunostaining for dystrophin localiza- 
tion along the sarcolemma in normal skeletal muscle fibers 
as revealed by confocal laser microscopy. The confocal laser 
microscope offers improved rejection of out-of-focus noise, 
thus, providing a sharper image of  any given focus plane with 
greater resolution than conventional imaging (White et al., 
Figure 3. Confocal laser image of a longitudinal section of the mus- 
cle fibers stained with antidystrophin. Regular cross striations are 
faintly observed inside the fibers (lines), corresponding to the dys- 
trophin staining along the sarcolemma (arrows). M, muscle fiber. 
Bar, 5 pm. 
Figure  4.  Confocal laser micrographs of the same section double 
stained with FITC-phalloidin (A) and Texas red-labeled antidystro- 
phin (B). Dystrophin staining image is superimposed onto the same 
field of phalloidin staining (C). The dot-like staining of dystrophin 
along the sarcolemma (arrows)  is found to locate at the same level 
of the phalloidin-stained I band. Bar,  1 #m. 
Masuda et al. Confocal Laser Microscopy of Dystrophin Localization  545 Figure 5. Confocal  laser micrographs of  sections cut tangential to the surface of  muscle fibers stained with antidystrophin  (A-C). Sarcomere- 
like cross-striated pattern is seen on the sarcolemma (arrowheads), while the longitudinal striations (arrows) run parallel to each other. 
Bars, 5  #m. 
1987).  Furthermore, such optical sectioning can minimize 
mechanical damages that might be caused by cutting thinner 
sections from frozen tissue blocks. The present observation 
suggests that dystrophin may not be uniformly distributed 
beneath the sarcolemma and may be spatially associated with 
the underlying myofibrils. 
The dystrophin localization at the sarcolemma has been 
well documented (Sugita et al.,  1988;  Zubrzycka-Gaarn et 
al., 1988;  Bonilla et al., 1988; Arahata et al.,  1988,  1989; 
Shimizu et al.,  1989;  Samitt and Bonilla,  1990;  Tanaka et 
al., 1990).  Many investigators described the continuous and 
uniform  immunostaining  ofdystrophin  along the sarcolemma 
using various antidystrophin antibodies. To our knowledge, 
no particular attention has been paid to the discontinuous  pat- 
tern of immunofluorescence  along the sarcolemma in normal 
human  and animal skeletal muscle fibers. Interestingly, favor- 
able sections in our preparations showed a discontinuous pat- 
tern of immunostaining even under a  conventional micro- 
scope.  Such a discontinuous pattern of staining was much 
more prominently demonstrated by confocal laser microscopy. 
The question naturally arises if such discontinuous stain- 
ing may be an artifact. Several candidates are conceivable for 
the possible sources of the artifact. First, the mAb (4-4C5) 
used may cause a peculiar reaction resulting in the observed 
staining pattern. It has been reported that a gene is expressed 
in muscles whose 3' terminal is highly homologous to the 3' 
terminal of dystrophin gene (Love et al., 1989). The product 
of the gene was named dystrophin-related protein. On West- 
ern blots it binds to a 400-kD protein in DMD patient and 
mdx mouse muscle as well as normal human and mouse 
muscle (Tanaka et al.,  1991; Ohlendieck et al.,  1991; Man 
et al., 1991). However,  4-4C5 which was raised against the 
COOH-terminal region of  dystrophin stained a 400-kD band 
in skeletal muscle samples from control human, but not in 
those from DMD patients (Tanaka and Ozawa, 1990; Tanaka 
et al.,  1991). This data showed that 4-4C5 was specific to 
dystrophin and did not react to the dystrophin-related pro- 
tein. Our Western blot analysis for guinea pig skeletal mus- 
cle also showed that 4-4C5 only reacted to the 400-kD dys- 
trophin band specifically and did not cross react with any 
other protein bands, including ct-actinin or spectrin. In addi- 
tion,  the  same  immunofluorescence result  was  obtained 
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stained with FITC-labeled antivinculin (A) and Texas red-labeled 
antidystrophin (B).  Dystrophin and  vinculin  are  colocalized at 
some spots (arrows). But there are other spots where they are not 
cotocalized (arrowheads). Bar, 1 ttm. 
using a polyclonal antibody raised in a  rabbit against syn- 
thetic fusion peptides containing the COOH-terminal region 
(kindly provided by Dr. Y. Nonomura, University of Tokyo). 
Secondly, our samples were prepared from unfixed muscle 
tissues as in many other studies for conventional immuno- 
fluorescence microscopy of dystrophin location. The mAb 
we used did not stain the formaldehyde-fixed muscle fibers. 
One might wonder if the sarcolemma in such unfixed muscle 
fibers have been damaged during the sample preparation, 
thus resulting in the discontinuous pattern of staining. How- 
ever, the staining was not random, often showing a lattice- 
like pattern of  transverse and longitudinal striations. Further- 
more, without the air-drying step before acetone treatment, 
we could obtain the same results.  This may reasonably ex- 
clude the possibility that the discontinuous pattern is caused 
by reorganization of the membrane cytoskeleton during the 
air-drying step.  Acetone treatment was applied to fix and 
permeabilize the tissue sections. Even if the sarcolemma has 
been damaged by the acetone treatment, it is still possible 
that the sarcolemma or dystrophin-associated structures be- 
neath the sarcolemma might be preferentially preserved in 
a nonrandom pattern. The membrane preservation often de- 
pends on the occurrence of underlying cytoskeletal compo- 
nents, namely the ptasmalemmal undercoat Oshikawa, 1988). 
The plasmalemmal  undercoat may provide the  structural 
support for the membrane and also serve as the link between 
the plasmalemma and cytoplasmic fibrous structures. Hence, 
the observed discontinuous staining  of dystrophin may be 
significant,  for dystrophin is  considered to constitute the 
membrane skeleton (Mandel,  1989) or the plasmalemmal 
undercoat. Such cytoskeleton may be unevenly distributed 
along the sarcolemma. 
Figure 7. Conventional epifluorescence (A) and confocal laser mi- 
crograph (B) of the myo-tendon junction in a guinea pig hind leg 
muscle stained with antidystrophin. (A) Intense immunostaining is 
observed at the ends (arrows) of muscle fiber (M), revealing the 
elaborate configuration. (B) The ends of  muscle fibers are intensely 
stained with a nonuniform pattern. Asterisks represent cut ends of 
sarcoplasmic processes of the fiber ends. Longitudinal striations 
(arrows) are also prominent on the lateral surface of the muscle 
fiber (M).  T, tendon tissue. Bars: (A) 10/~m; (B) 5/zm. 
Interestingly, in longitudinal sections the dystrophin stain- 
ing pattern appeared to correspond to the cross striation of 
the underlying myofibrils. The center-to-center distance be- 
tween the fluorescent dots was 1-3 #m. The superimposition 
analysis of double-stained samples with the confocal laser 
microscope clearly indicated that the fluorescent dots along 
the sarcolemma tended to be situated at the same level of the 
I band which was stained with fluorescent dye-labeled phal- 
loidin. This implies that dystrophin may be located in the 
structure which is preserved during our specimen prepara- 
tion and is situated preferentially at the level of the I band 
or Z disc. In immunoelectron microscopic studies, the occa- 
sional periodicity of dystrophin labeling on the sarcolemma 
has been pointed out (Watkins  et al.,  1988; Cullen et al., 
1990). The periodicity was ,o125 nm in both transverse and 
longitudinal sections. This value corresponds well with the 
estimated length of a  dystrophin molecule (Koenig et al., 
1988) but not with the length of the sarcomere or the gap be- 
tween adjacent myofibrils. 
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staining of dystrophin along the sarcolemma at the myo-ten- 
don junction, confirming the recent observations (Shimizu 
et al.,  1989; Samitt and Bonilla, 1990). On the other hand, 
EM revealed that most of the sarcolemma at the myo-tendon 
junction is lined with a layer of dense material as we call the 
plasmalemmai undercoat (Ishikawa, 1988). In our correlated 
confocal laser and thin section EM, the immunofluorescence 
of dystrophin and the electron-dense undercoat showed the 
same distribution at the ends of muscle fibers (our own un- 
published data).  Clearly,  dystrophin stain was localized at 
the dense undercoat at the end portion of the muscle fiber. 
At the myo-tendon junction the undercoat possesses two do- 
mains:  a  myofibril-anchored domain  and an  intermediate 
filament-associated  domain  (Ishikawa,  1988).  It  is  inter- 
esting to ask how dystrophin is associated  with such do- 
mains at the myo-tendon junction. In this connection, the 
observation  deserves  attention  to  the  fact  that  the  sar- 
colemma in the central portion of the muscle fiber is also 
lined with the electron-dense undercoats in a scattered man- 
ner. Such undercoats appear to serve as the attachment sites 
for intermediate filaments, which run transversely to be as- 
sociated with myofibrils at the Z disc level. However, it has 
not been decided how the intermittent pattern of dystrophin 
localization is related to the undercoat in the central portion 
of the muscle fiber. 
Vinculin-contalning cortical lattice named costamere has 
been reported to be localized at the sarcolemma. In the lon- 
gitudinal sections of muscle  fibers,  the costameres  always 
overlie the I band (Pardo et al.,  1983a,b; Shear and Bloch, 
1985; Tokuyasu, 1989). In the present study, double immu- 
nostaining for dystrophin and vinculin revealed that the two 
proteins were  not exactly colocalized.  Further studies are 
needed to clarify how dystrophin is related to the vinculin- 
containing costameres. 
We wish to thank Professor Y. Nonomura, Department of Pharmacology, 
Faculty of Medicine, University of Tokyo, for the gift of polyclonal an- 
tidystrophin antibody. 
This work was supported in part by Grants-in-Aid for Scientific Re- 
search from the National Center for Nervous, Mental, and Muscular Dis- 
orders of the Ministry of Health and Welfare, Japan, and from the Ministry 
of Education, Science and Culture, Japan. 
Received for publication 11 May 1992 and in revised form 8 July 1992. 
References 
Arahata, K., S. Ishiura, T. Ishiguro, T. Tsukahara, Y. Suhara, C. Eguchi, T. 
Ishihara, I.  Nonaka, E.  Ozawa, and H. Sugita.  1988.  Immunostaining of 
skeletal  and  cardiac  muscle  surface  membrane  with  antibody  against 
Duchenne muscular dystrophy peptide. Nature (Lond.).  333:861-863. 
Arahata, K., T. Ishihara, K. Kamakuru, T. Tsukahara, S. Ishiura, C. Baha, T. 
Matsumoto, I. Nonaka, and H. Sugita. 1989. Mosaic expression of dystro- 
phin in symptomatic carders of Duchenne's muscular dystrophy. N. Engl. 
J.  Med. 320:138-142. 
Bonilla, E., C. E. Samitt, A. F. Miranda, A. P. Hays, G. Salviati,  S. DiMauro, 
L. M. Kunkel, E. P. Hoffman, and L. P. Rowland. 1988. Duchennc muscu- 
lar dystrophy: deficiency of dystrophin at the muscle cell surface. Cell. 
54:447-452. 
Cooper, A. R., M. Kurkinen, A. Taylor, and B. L. M. Hogan. 1981. Studies 
on the biosynthesis of laminin by routine parietal endoderm cells. Eur.  k 
Biochem.  119:189-197. 
Cullen, M. J., J. Walsh, L. V. B. Nicholson, andJ. B. Harris. 1990. Ultrastruc- 
tural localization of dystrophin in human muscle  by using gold immunolabel- 
ling. Proc. R.  Soc.  Lond,  B.  Biol.  Sci.  240:197-210, 
Hoffman, E. P., R. H. Brown, Jr., and L. M. Kankel. 1987. Dystrophin: the 
protein  product  of the  Duchenne muscular dystrophy  locus.  Cell.  51: 
919-928. 
Hoffman, E. P., K, H. Fischbeck, R. H. Brown, M. Johnson, R. Medori, J. D. 
Loike, J. B. Harris, R. Waterston, M. Brooke, L. Specht, W. Kupsky, J. 
Chamberlain, C. T. Caskey, F. Shapiro, and L. M. Kunkel.  1988.  Char- 
acterization of dystruphin in muscle-biopsy specimens from patients with 
Duchenne's or Becker's muscular dystrophy. N. Engl.  J. Med. 318:1363- 
1368. 
Ishikawa, H. 1988. Ptasmalemmal undercoat: the eytoskeleton supporting the 
plasmalemma. Arch. Histol.  Cytol.  51:127-145. 
Kocnig, M., E. P. Hoffman, C. J. Berteison, A. P. Monaco, C. Feener, and 
L. M. Kunkel. 1987. Complete cloning of  the Duchenne muscular  dystrophy 
(DMD) eDNA and preliminary genomic organization of the DMD gene in 
normal and affected individuals. Cell.  50:509-517. 
Koenig, M., A. P, Monaco, and L. M. Kunkel. 1988. The complete sequence 
of dystrophin predicts a rod-shaped cytoskeletal  protein. Cell. 53:219-228. 
Laemmii, U. K. 1970. Cleavage of structural proteins during the assembly of 
the head of bacteriophage. Nature (Lond.).  227:680-685. 
Love, D. R., D. F. Hill, G. Dickson, N. K. Spurt, B. C. Byth, R. F. Marsden, 
F. S. Walsh, Y. H. Edwards, and K. E. Davies. 1989. An autosomal tran- 
script in skeletal muscle with homology to dystrophin. Nature  (Lord.). 
339:55-58. 
Man, N. T., J. M. Ellis, D. R. Love, K. E. Davies, K. C. Garter, G. Dickson, 
and  G.  E.  Morris.  199I.  Localization  of  the  DMDL  gene-cncoded 
dystrophin-related protein using a panel of nineteen monoclonal antibodies: 
presence at neuromuscular  junctions, in the sarcolemma  of dystrophic skele- 
tal muscle, in vascular and other smooth muscles, and in proliferating brain 
celt lines. J.  Cell Biol.  115:1695-1700. 
Mandel, J. L. 1989. The gene and its product. Nature (Lond.).  339:584-586. 
Ohlendieck, K., J, M. Ervasti, K. Matsumura, S. D. Kahl, C. J. Leveille, and 
K. P. Campbell. 1991. Dystrophin-related protein is localized to neuromus- 
cular junctions of adult skeletal muscle. Neuron, 7:499-508. 
Pardo, L  V., J. D. Siliciano,  and S. W. Craig.  1983a.  A vinculin-contalning 
cortical lattice in skeletal muscle: Transverse lattice elements (~costameres") 
mark sites of attachment between myofihriis and sarcolemma. Proc. Natl. 
Acad. Sci.  USA.  80:1008-1012. 
Pardo, L V., J. D. Siliciano,  and St W. Craig. 1983b. Vinculin is a component 
of an extensive network of myofibril-sarcolemma attachment regions in 
cardiac muscle fibers.  J.  Cell Biol.  97:1081-1088. 
Samitt, C. E., and E. Bonilla.  1990. Immunocytochemical study of dystrophin 
at the myotendinous junction. Muscle and Nerve.  13:493-500. 
Shear, C. R., and R. J. Bloch.  1985. Vinculin in subsarcolemmal densities in 
chicken skeletal muscle: localization  and relationship to intracellular and ex- 
tracellular structures. J.  Cell Biol.  101:240-256. 
Shimizu, T., K. Matsumura, Y. Sunada, and T.  Mannen.  1989.  Dense im- 
munostainings  on both neuromuscular  and myotendon  junctions with an anti- 
dystrophin monoclonal antibody. Biomed.  Res.  10:405-409. 
Sugita, H., K. Arahata, T. Ishiguro, Y. Suhara, T. Tsukahara, S. Ishiura, C. 
Eguchi)  L  Nonaka,  and  E.  Ozawa.  1988.  Negative immunostaining of 
Duchenne muscular dystrophy (DMD) and mdx muscle surface membrane 
with  antibody against synthetic peptide  fragment predicted  from DMD 
eDNA. Proc. Jpn. Acad.  64B:37-39. 
Tanaka, H., and E. Ozawa, 1990. Expression ofdystrophin mRNA and the pro- 
tein  in  the  developmental rat  heart.  Biochem.  Biophys.  Res.  Commun. 
172:824-829. 
Tanaka, H., K. Ikeya, E. Ozawa.  1990.  Difference in the expression pattern 
of dystrophin on the surface  membrane  between the skeletal and cardiac mus- 
cles of mdx carrier mice. Histochemistry.  93:447-452. 
Tanaka, H., T. Ishiguro, C. Eguchi, K. Saito, and E. Ozawa. 1991. Expression 
of a dystrophin-related protein associated with the skeletal muscle cell mem- 
brane. Histochemistry.  96:1-5. 
Tokuyasu, K. T. 1989, Immunocytochemical  studies of  cardiac myofibrillogen- 
esis in early chick embryos. IIL C-cneration of fasciae adherentes and costa- 
meres. J.  Cell Biol.  108:43-53. 
Wakayama, Y., and S.  Shibuya.  1990.  Observations on the muscle plasma 
membrane-associated  cytoskeletons of mdx mice by quick-freeze, deep-etch, 
rotary-shadow replica method. Acta. Neuropathol.  80:618-623. 
Wakayama, Y., and S. Shibuya. 1991.  Antibody-decorated dystrophin mole- 
cule of murine skeletal  myofiber as seen by freeze-etching electron micros- 
copy. J. Electron Microsc.  40:143-145. 
Watkins, S. C., E. P. Hoffman, H. S. Slayter, and L. M. Kunkel. 1988. Immu- 
noelectron  microscopic localization  of dystrophin in  myofibres.  Nature 
(Lord.).  333:863-866. 
White, J. C, W. B. Amos, and M. Fordham. 1987. An evaluation of confocal 
versus conventional imaging of biological structures by fluorescence light 
microscopy. J.  Cell Biol.  105:41-48. 
Wulf, E., A. Deboben, F. A. Bantz, H. Faulstich, and Th. Wieland. 1979. Flu- 
orescent PhaUotoxin, a tool for the visualization  of celhilar actin. Proc. Nail. 
Acad. Sci.  USA.  76:4498-4502. 
Zubrzycka-Gaarn, E. E.,  D. E. Bulman, G. Karpati, A. H. M. Burghes, B. 
Belfall, H. J. Klamut, J. Talbot, R. S. Hodges, P. N. Ray, and R. G. Wor- 
ton.  1988.  The Duchenne muscular dystrophy gene product is localized  in 
sarcolemma of human skeletal  muscle. Nature (Lond.).  333:466-469. 
The Journal of Cell Biology, Volume 119,  1992  548 